Kerafast facilities access to unique reagents developed in academic labs, including coronavirus antibodies and a Delta-G-VSV pseudotyping system that enables studies of viral entry and vaccine effectiveness at just BSL-2 containment. If your lab has created reagents that you would like to share quickly for COVID-related research, our program can help. Learn more here, or contact us at community@kerafast.com.